Quarterly report · Q2
4202.TEDINET S100S6J5
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥271.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥538.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥266.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥26.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥26.0bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥30.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥52.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥30.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥40.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥32.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥29.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥40.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥22.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥29.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥22.8bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥808.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥765.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥746.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥453.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥455.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥355.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥310.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥311.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥97.6bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥93.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥92.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥93.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥85.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥88.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥49.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥26.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥44.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥28.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥104.13 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.67 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.87 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.08 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.97 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 65
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥9.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥108.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥108.7bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥71m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥95.7bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥91.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥21.1bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥481m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥140m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.8bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.7bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥153m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥1.1bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥273.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥268.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥282.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥271.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥9.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥13.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥13.9bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥123.7bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥123.6bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥157m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥82.6bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥75.2bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.4bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥10.4bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥8.1bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥8.0bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥702m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥39.7bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥39.7bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥16m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥74m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥373m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥270.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥262.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥25.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥280.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥266.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥26.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 574
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | 8133000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 16238000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | 39745000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 82613000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 123717000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 270448000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9718000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 280166000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -13933000000 | JPY |
| Net sales | Prior1YTDDuration | 266232000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | 702000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 373000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | -16000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 10386000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 14461000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 25907000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 118000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 26026000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 26026000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | 6877000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 14683000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | 47132000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 91125000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 108696000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 268514000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2490000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 271004000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 271004000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 153000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 4619000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 71000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 4844000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6907000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11751000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -11751000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | 6877000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 14837000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | 47132000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 95744000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 108767000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 273359000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9397000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 282756000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -11751000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |